JP2009536188A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536188A5
JP2009536188A5 JP2009508479A JP2009508479A JP2009536188A5 JP 2009536188 A5 JP2009536188 A5 JP 2009536188A5 JP 2009508479 A JP2009508479 A JP 2009508479A JP 2009508479 A JP2009508479 A JP 2009508479A JP 2009536188 A5 JP2009536188 A5 JP 2009536188A5
Authority
JP
Japan
Prior art keywords
compound
valine
formula
compound according
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009508479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009536188A (ja
JP5261374B2 (ja
Filing date
Publication date
Priority claimed from GBGB0609178.9A external-priority patent/GB0609178D0/en
Application filed filed Critical
Publication of JP2009536188A publication Critical patent/JP2009536188A/ja
Publication of JP2009536188A5 publication Critical patent/JP2009536188A5/ja
Application granted granted Critical
Publication of JP5261374B2 publication Critical patent/JP5261374B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009508479A 2006-05-09 2007-05-09 抗ウイルス性ピリミジンヌクレオシド誘導体 Expired - Fee Related JP5261374B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0609178.9A GB0609178D0 (en) 2006-05-09 2006-05-09 Novel compounds
GB0609178.9 2006-05-09
PCT/GB2007/001677 WO2007129083A1 (en) 2006-05-09 2007-05-09 Anti-viral pyrimidine nucleoside derivatives

Publications (3)

Publication Number Publication Date
JP2009536188A JP2009536188A (ja) 2009-10-08
JP2009536188A5 true JP2009536188A5 (enExample) 2011-01-13
JP5261374B2 JP5261374B2 (ja) 2013-08-14

Family

ID=36637171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009508479A Expired - Fee Related JP5261374B2 (ja) 2006-05-09 2007-05-09 抗ウイルス性ピリミジンヌクレオシド誘導体

Country Status (22)

Country Link
US (3) US8329664B2 (enExample)
EP (1) EP2016081B1 (enExample)
JP (1) JP5261374B2 (enExample)
KR (1) KR101447522B1 (enExample)
CN (1) CN101443332B (enExample)
AT (1) ATE506367T1 (enExample)
AU (1) AU2007246814B2 (enExample)
BR (1) BRPI0711354A2 (enExample)
CA (1) CA2656780C (enExample)
CY (1) CY1111711T1 (enExample)
DE (1) DE602007014030D1 (enExample)
DK (1) DK2016081T3 (enExample)
EA (1) EA015178B1 (enExample)
ES (1) ES2365057T3 (enExample)
GB (1) GB0609178D0 (enExample)
IL (1) IL194806A (enExample)
NZ (1) NZ573377A (enExample)
PL (1) PL2016081T3 (enExample)
PT (1) PT2016081E (enExample)
SI (1) SI2016081T1 (enExample)
TW (1) TWI385172B (enExample)
WO (1) WO2007129083A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009486D0 (en) * 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
GB2452556A (en) * 2007-09-07 2009-03-11 Univ Leuven Kath Nucleoside analogues esterified at 3 and/or 5 positions by neutral non-polar amino acid, or oligopeptide thereof, for combating Varicella Zoster virus
US9260469B2 (en) * 2010-10-09 2016-02-16 Contravir Pharmaceuticals, Inc. Method of preparation of antiviral compounds and useful intermediates thereof
CN105037468A (zh) * 2010-10-09 2015-11-11 英希比泰克斯公司 制备抗病毒组合物的方法及其中间体的应用
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс
KR101875997B1 (ko) * 2015-05-04 2018-07-06 엔 앤드 엔 파마세우티칼스 인크. 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
EP0346108A3 (en) 1988-06-09 1991-04-24 The Wellcome Foundation Limited Anti-infective nucleosides
YU43193A (sh) 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
GB9505025D0 (en) 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
US6022876A (en) * 1996-11-15 2000-02-08 Yale University L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections
GB9708611D0 (en) 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
GB9716231D0 (en) 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues
MXPA02000763A (es) 1999-07-22 2002-08-12 Newbiotics Inc Activacion terapeutica catalizada por enzima.
MXPA02000761A (es) 1999-07-22 2002-08-12 Newbiotics Inc Agentes terapeuticos anti-infecciosos catalizados por enzima.
CN1391486A (zh) 1999-07-22 2003-01-15 新生物公司 治疗对治疗有抗性的肿瘤的方法
GB0009486D0 (en) * 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
GB0011203D0 (en) * 2000-05-09 2000-06-28 Univ Cardiff Chemical compounds
MY141594A (en) * 2000-06-15 2010-05-14 Novirio Pharmaceuticals Ltd 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
US6875751B2 (en) 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
CA2490191C (en) 2002-06-28 2010-08-03 Idenix (Cayman) Limited Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
EP1745573A4 (en) * 2003-03-20 2010-05-26 Microbiol Quimica Farmaceutica PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
US20050137141A1 (en) 2003-10-24 2005-06-23 John Hilfinger Prodrug composition
JP4856638B2 (ja) 2004-06-07 2012-01-18 アナディス・ファーマシューティカルズ・インコーポレイテッド 3−β−D−リボフラノシルチアゾロ[4,5−d]ピリミジンヌクレオシドおよびその使用

Similar Documents

Publication Publication Date Title
JP2009536188A5 (enExample)
CA2615921A1 (en) Hepatitis c inhibitor peptide analogs with a quinoline or a thienopyridine moiety
JP2006182786A5 (enExample)
JP2008509166A5 (enExample)
JP2009502743A5 (enExample)
JP2005523922A5 (enExample)
JP2009519243A5 (enExample)
CA2686997A1 (en) Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
JP2011527333A5 (enExample)
JP2006514626A5 (enExample)
JP2011505356A5 (enExample)
JP2006523214A5 (enExample)
JP2011523952A5 (enExample)
CA2684556A1 (en) Novel therapeutic uses of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine
JP2004529172A5 (enExample)
JP2017518363A5 (enExample)
US20150202218A1 (en) Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus Infections
JP2012511558A5 (enExample)
CN101443332B (zh) 抗病毒嘧啶核苷衍生物
JP2008544975A5 (enExample)
JP2006500372A5 (enExample)
EP2528891A2 (en) Processes for reducing impurities in lacosamide
JP2008534537A5 (enExample)
JP2004502767A5 (enExample)
JP2011512336A5 (enExample)